Claims
- 1. A method of providing a cytoprotective effect in a subject in need thereof, said method comprising administering to said subject an effective dose of a pharmaceutical composition in the form of an aqueous solution, comprising:
- a salt of azelastine selected from a member of the group consisting of azelastine acetate, azelastine gluconate, azelastine lactate and azelastine malate wherein when the salt is azelastine acetate the solubility of the salt in aqueous solution is at least about 2%, when the salt is azelastine malate or azelastine lactate the solubility of the salt in aqueous solution is at least about 3%, and when the salt is azelastine gluconate the solubility of the salt in aqueous solution is at least about 5%,
- and a member of the group consisting of pharmaceutically-acceptable carriers and diluents therefor.
- 2. The method as set forth in claim 1 wherein the salt is azelastine acetate or azelastine lactate and the solubility of the salt in aqueous solution is at least about 10%.
Priority Claims (1)
Number |
Date |
Country |
Kind |
39 14 859 |
May 1989 |
DEX |
|
Parent Case Info
This is a division of application Ser. No. 08/691,415, filed Aug. 2, 1996, U.S. Pat. No. 5,859,003, which is a continuation of Ser. No. 08/281,973, filed Jul. 29, 1994, now abandoned, which is a continuation of Ser. No. 07/519,172, filed May 4, 1990, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3813384 |
VogelSang |
May 1974 |
|
4868175 |
Engle |
Sep 1989 |
|
Foreign Referenced Citations (3)
Number |
Date |
Country |
0 316 639 |
Oct 1988 |
EPX |
63-218622 |
Sep 1988 |
JPX |
0 124 824 |
May 1990 |
JPX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
691415 |
Aug 1996 |
|
Continuations (2)
|
Number |
Date |
Country |
Parent |
281973 |
Jul 1994 |
|
Parent |
519172 |
May 1990 |
|